drugset / Trial / NCT06471231

Renal Outcomes in the Early Use of Vasopressin in the Treatment of Septic Shock

NCT06471231

Phase 4 Unknown 264 enrolled Azienda Usl di Bologna
RandomizedParallel-groupSingle-blindPrevention

Summary

The aim of the present study is to verify whether the earlier association of vasopressin and norepinephrine, in patients in septic shock, determines variations in terms of use of renal function replacement techniques in the first 7 days of hospitalization in Intensive Care, compared to patients in whom vasopressin is added only when norepinephrine reaches a higher dose.

Timeline

Start
2024-05-15
Primary completion
2026-05-15
Completion
2026-05-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Vasopressin Peptide 0.3 iu